106 related articles for article (PubMed ID: 20486347)
21. [Study on the effect of treatment and the status of drug resistance among HIV/AIDS patients treated with highly active antiretroviral therapy in Shandong province].
Zhang J; Lin B; Lin L; Yang PJ; Fu JH; Li HP; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1108-11. PubMed ID: 18396667
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
[TBL] [Abstract][Full Text] [Related]
23. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
24. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
25. [Cytomegalovirus retinitis and ocular complications in AIDS patients in Togo].
Balo KP; Amoussou YP; Béchetoille A; Mihluedo H; Djagnikpo PA; Akpandja SM; Banla M
J Fr Ophtalmol; 1999 Dec; 22(10):1042-6. PubMed ID: 10617841
[TBL] [Abstract][Full Text] [Related]
26. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
Tangsinmankong N; Kamchaisatian W; Lujan-Zilbermann J; Brown CL; Sleasman JW; Emmanuel PJ
J Allergy Clin Immunol; 2004 Apr; 113(4):742-6. PubMed ID: 15100682
[TBL] [Abstract][Full Text] [Related]
27. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
28. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
[TBL] [Abstract][Full Text] [Related]
29. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
30. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
31. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
32. Long-term study of intraocular pressure changes in patients with human immunodeficiency virus treated with highly active antiretroviral therapy.
Kozak I; LaBree L; Azen SP; Cheng L; Reagan NL; Freeman WR
Ophthalmology; 2006 Mar; 113(3):451-5. PubMed ID: 16513459
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma in a hospital setting in Lomé (Togo): a study of 93 cases.
Pitche PT; Kombate K; Owono F; Tchangai-Walla K
Int J Dermatol; 2007 Oct; 46 Suppl 1():42-4. PubMed ID: 17919207
[TBL] [Abstract][Full Text] [Related]
35. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
[TBL] [Abstract][Full Text] [Related]
36. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
37. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
38. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
[TBL] [Abstract][Full Text] [Related]
39. Ocular Manifestations of Acquired Immunodeficiency Syndrome.
Kim YS; Sun HJ; Kim TH; Kang KD; Lee SJ
Korean J Ophthalmol; 2015 Aug; 29(4):241-8. PubMed ID: 26240508
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001.
Beck EJ; Mandalia S; Gaudreault M; Brewer C; Zowall H; Gilmore N; Klein MB; Lalonde R; Piché A; Hankins CA
AIDS; 2004 Dec; 18(18):2411-8. PubMed ID: 15622317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]